$18.29
0.27% yesterday
Nasdaq, Oct 09, 10:00 pm CET
ISIN
US68401U2042
Symbol
OPRX

OptimizeRx Corporation Stock price

$18.29
+0.50 2.81% 1M
+10.00 120.63% 6M
+13.43 276.34% YTD
+11.90 186.23% 1Y
+3.25 21.61% 3Y
-0.75 3.94% 5Y
+14.42 372.61% 10Y
-386.71 95.48% 20Y
Nasdaq, Closing price Thu, Oct 09 2025
+0.05 0.27%
ISIN
US68401U2042
Symbol
OPRX

Key metrics

Basic
Market capitalization
$339.6m
Enterprise Value
$351.4m
Net debt
$11.8m
Cash
$16.6m
Shares outstanding
18.6m
Valuation (TTM | estimate)
P/E
negative | 27.0
P/S
3.2 | 3.1
EV/Sales
3.4 | 3.2
EV/FCF
34.9
P/B
2.9
Financial Health
Equity Ratio
68.4%
Return on Equity
-17.2%
ROCE
-2.6%
ROIC
-2.8%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$104.8m | $108.6m
EBITDA
$500.0k | $16.2m
EBIT
$-3.9m | $4.3m
Net Income
$-9.9m | $12.6m
Free Cash Flow
$10.1m
Growth (TTM | estimate)
Revenue
25.9% | 17.9%
EBITDA
102.5% | 958.6%
EBIT
83.4% | 168.3%
Net Income
44.9% | 162.5%
Free Cash Flow
703.0%
Margin (TTM | estimate)
Gross
64.4%
EBITDA
0.5% | 14.9%
EBIT
-3.7%
Net
-9.4% | 11.6%
Free Cash Flow
9.6%
More
EPS
$-0.5
FCF per Share
$0.5
Short interest
9.9%
Employees
129
Rev per Employee
$710.0k
Show more

Is OptimizeRx Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,998 stocks worldwide.

OptimizeRx Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a OptimizeRx Corporation forecast:

11x Buy
85%
2x Hold
15%

Analyst Opinions

13 Analysts have issued a OptimizeRx Corporation forecast:

Buy
85%
Hold
15%

Financial data from OptimizeRx Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
105 105
26% 26%
100%
- Direct Costs 37 37
18% 18%
36%
67 67
31% 31%
64%
- Selling and Administrative Expenses 59 59
5% 5%
57%
- Research and Development Expense - -
-
-
0.50 0.50
103% 103%
0%
- Depreciation and Amortization 4.36 4.36
20% 20%
4%
EBIT (Operating Income) EBIT -3.85 -3.85
83% 83%
-4%
Net Profit -9.87 -9.87
45% 45%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about OptimizeRx Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OptimizeRx Corporation Stock News

Positive
Seeking Alpha
about 22 hours ago
Healthcare stocks quietly outperformed the market in the past 30 days as headlines centered on the government shutdown over the extension of Affordable Care Act tax credits for 2026. The AI in healthcare market is expected to reach $504B by 2032, driven by an aging population, medical data explosion, job shortages, and consumer demand for self-care technology. Healthcare companies are increasin...
Positive
Seeking Alpha
2 days ago
OptimizeRx Corporation is evolving from an EHR messaging platform to a clinical data and AI-driven advertising company, leveraging DAAP and MNT technologies. Q2 2025 financials show strong revenue growth, improved margins, and a shift to higher-margin subscription revenues, supporting management's raised guidance for 2025. The Lamar partnership and expanding mid-tier pharma client base diversif...
Neutral
GlobeNewsWire
30 days ago
WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September...
More OptimizeRx Corporation News

Company Profile

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Head office United States
CEO Stephen Silvestro
Employees 129
Founded 1985
Website www.optimizerx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today